Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine administration methods in thoracoscopic pulmonary surgery
ChiCTR2300069247Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine (5 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoints: Inflammatory factors and oxidative stress factors in serum and exhaled breath condensate and Hemodynamics. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2300069247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069247.